Clinitech Laboratory Ltd vs Indraprastha Medical Corporation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Clinitech Laboratory Ltd is ₹ 32 as of 07 Oct 15:30 . The P/E Ratio of Clinitech Laboratory Ltd is 23.3 as of March 2025 .The P/E Ratio of Indraprastha Medical Corporation Ltd is 0 as of March 2025 . The Market Cap of Clinitech Laboratory Ltd is ₹ 9.18 crore as of March 2025 .The Market Cap of Indraprastha Medical Corporation Ltd is ₹ 0 crore as of March 2025 . The revenue of Clinitech Laboratory Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Indraprastha Medical Corporation Ltd for the Jun '26 is ₹ 414.57 crore as compare to the Mar '26 revenue of ₹ 372.14 crore. This represent the growth of 11.4% The ebitda of Clinitech Laboratory Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Indraprastha Medical Corporation Ltd for the Jun '26 is ₹ 88.23 crore as compare to the Mar '26 ebitda of ₹ 67.84 crore. This represent the growth of 30.06% The net profit of Clinitech Laboratory Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Indraprastha Medical Corporation Ltd changed from ₹ 44.77 crore to ₹ 55.85 crore over 9 quarters. This represents a CAGR of 10.33% The Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 years .

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.

FAQs for the comparison of Clinitech Laboratory Ltd and Indraprastha Medical Corporation Ltd

Which company has a larger market capitalization, Clinitech Laboratory Ltd or Indraprastha Medical Corporation Ltd?

Market cap of Clinitech Laboratory Ltd is 7 Cr while Market cap of Indraprastha Medical Corporation Ltd is 2,749 Cr

What are the key factors driving the stock performance of Clinitech Laboratory Ltd and Indraprastha Medical Corporation Ltd?

The stock performance of Clinitech Laboratory Ltd and Indraprastha Medical Corporation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Clinitech Laboratory Ltd and Indraprastha Medical Corporation Ltd?

As of October 25, 2026, the Clinitech Laboratory Ltd stock price is INR ₹32.0. On the other hand, Indraprastha Medical Corporation Ltd stock price is INR ₹299.95.

How do dividend payouts of Clinitech Laboratory Ltd and Indraprastha Medical Corporation Ltd compare?

To compare the dividend payouts of Clinitech Laboratory Ltd and Indraprastha Medical Corporation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.